Works about PROTEASOME inhibitors

Results: 1165
    1
    2

    Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.

    Published in:
    Leukemia & Lymphoma, 2025, v. 66, n. 7, p. 1234, doi. 10.1080/10428194.2025.2476655
    By:
    • Amrein, Philip C.;
    • Preffer, Frederic I.;
    • Fell, Geoffrey;
    • Attar, Eyal C.;
    • Narayan, Rupa;
    • Blonquist, Traci M.;
    • Brunner, Andrew M.;
    • Hobbs, Gabriela S.;
    • Hock, Hanno R.;
    • McAfee, Steven L.;
    • Moran, Jenna A.;
    • Bergeron, Meghan K.;
    • Foster, Julia E.;
    • Bertoli, Christina;
    • McGregor, Kristin;
    • Connolly, Christine;
    • Behnan, Tanya T.;
    • Som, Tina T.;
    • Ramos, Aura Y.;
    • Vartanian, Megan K.
    Publication type:
    Article
    3

    Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance.

    Published in:
    PLoS Biology, 2015, v. 13, n. 4, p. 1, doi. 10.1371/journal.pbio.1002132
    By:
    • Dogovski, Con;
    • Xie, Stanley C.;
    • Burgio, Gaetan;
    • Bridgford, Jess;
    • Mok, Sachel;
    • McCaw, James M.;
    • Chotivanich, Kesinee;
    • Kenny, Shannon;
    • Gnädig, Nina;
    • Straimer, Judith;
    • Bozdech, Zbynek;
    • Fidock, David A.;
    • Simpson, Julie A.;
    • Dondorp, Arjen M.;
    • Foote, Simon;
    • Klonis, Nectarios;
    • Tilley, Leann
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Role of TRIM24 in the regulation of proteasome-autophagy crosstalk in bortezomib-resistant mantle cell lymphoma.

    Published in:
    Cell Death Discovery, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41420-025-02355-6
    By:
    • Bouvier, Corentin;
    • Gonzalez-Santamarta, Maria;
    • Profitós-Pelejà, Núria;
    • Armengol, Marc;
    • Quinet, Grégoire;
    • Alasseur, Quentin;
    • Ceccato, Laurie;
    • Xolalpa, Wendy;
    • Freire, Raimundo;
    • Guillermet-Guibert, Julie;
    • Reybier, Karine;
    • Caminade, Anne-Marie;
    • Beck, Hans C.;
    • Carvalho, Ana Sofia;
    • Matthiesen, Rune;
    • Rain, Jean Christophe;
    • Sutherland, James D.;
    • Barrio, Rosa;
    • Roué, Gaël;
    • Rodriguez, Manuel S.
    Publication type:
    Article
    13
    14
    15
    16
    17

    Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 12, p. 3355, doi. 10.3390/jcm11123355
    By:
    • Gavriilaki, Eleni;
    • Dalampira, Dimitra;
    • Theodorakakou, Foteini;
    • Liacos, Christine-Ivy;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Verrou, Evgenia;
    • Triantafyllou, Theodora;
    • Sevastoudi, Aggeliki;
    • Koravou, Evaggelia-Evdoxia;
    • Touloumenidou, Tasoula;
    • Varelas, Christos;
    • Papalexandri, Apostolia;
    • Sakellari, Ioanna;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios;
    • Katodritou, Eirini
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Dynamic Metabolic and Transcriptional Responses of Proteasome-Inhibited Neurons.

    Published in:
    Antioxidants, 2023, v. 12, n. 1, p. 164, doi. 10.3390/antiox12010164
    By:
    • Suciu, Ilinca;
    • Delp, Johannes;
    • Gutbier, Simon;
    • Ückert, Anna-Katharina;
    • Spreng, Anna-Sophie;
    • Eberhard, Philipp;
    • Karreman, Christiaan;
    • Schreiber, Falk;
    • Madjar, Katrin;
    • Rahnenführer, Jörg;
    • Celardo, Ivana;
    • Amelio, Ivano;
    • Leist, Marcel
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56318-7
    By:
    • Arseni, Lavinia;
    • Sigismondo, Gianluca;
    • Yazdanparast, Haniyeh;
    • Hermansen, Johanne U.;
    • Mack, Norman;
    • Ohl, Sibylle;
    • Kalter, Verena;
    • Iskar, Murat;
    • Kalxdorf, Mathias;
    • Friedel, Dennis;
    • Rettel, Mandy;
    • Paul, Yashna;
    • Ringshausen, Ingo;
    • Eldering, Eric;
    • Dubois, Julie;
    • Kater, Arnon P.;
    • Zapatka, Marc;
    • Roessner, Philipp M.;
    • Tausch, Eugen;
    • Stilgenbauer, Stephan
    Publication type:
    Article
    49
    50

    ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation.

    Published in:
    Stem Cell Research & Therapy, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13287-020-02037-3
    By:
    • Zhang, Dan;
    • De Veirman, Kim;
    • Fan, Rong;
    • Jian, Qiang;
    • Zhang, Yuchen;
    • Lei, Li;
    • Evans, Holly;
    • Wang, Yanmeng;
    • Lei, Lei;
    • Wang, Baiyan;
    • Williamson, Ramone A.;
    • Chantry, Andrew;
    • He, Pengcheng;
    • Li, Ang;
    • De Raeve, Hendrik;
    • Vanderkerken, Karin;
    • He, Aili;
    • Hu, Jinsong
    Publication type:
    Article